Form 10-Q · Quarterly report
Altria 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0000764180
- Accession no.
- 0000764180-26-000114
Summary
Altria reported third-quarter 2026 net earnings of $2.52 billion, or $1.51 per diluted share (adjusted $1.52), and nine-month net earnings of $6.999 billion, or $4.18 per diluted share (adjusted $4.33). The company said domestic cigarette shipment volume fell about 4% year over year while discount brands reached 34.1% of retail cigarette share and nicotine pouches grew to 61.2% of the U.S. oral tobacco category.
Key points
- Altria's third-quarter 2026 reported diluted EPS rose 7.1% to $1.51 and adjusted diluted EPS rose 4.8% to $1.52 versus the prior-year quarter.
- Nine-month 2026 reported diluted EPS rose 21.2% to $4.18, with adjusted diluted EPS up 5.1% to $4.33.
- Total estimated U.S. cigarette industry volume declined about 5% in the third quarter of 2026 versus a year earlier, and Altria's smokeable products segment cigarette shipment volume declined about 4% on a trade-inventory-adjusted basis.
- Altria said U.S. inflation was 3.7% in September with gasoline averaging $4.36 per gallon, pressuring adult nicotine consumers' discretionary income.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Summary Our Business We are a leader in nicotine with a growing portfolio of products for adult nicotine consumers age 21+. Today, we are focused on elevating everyday moments by offering adult nicotine consumers a range of product choices and the information they need to make informed decisions. We are Moving Beyond Smoking® by responsibly transitioning adult smokers to a smoke-free future, competing vigorously for existing smoke-free adult nicotine consumers and exploring new growth opportunities - beyond the United States and beyond nicotine (“Vision”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.